NuuVim review
NuuVim advertises semaglutide at $79 a month. That is a new-patient rate billed as one $237 payment; the standard rate is $133, and no one-month price exists.
- Pricing grade
- CCaveat
- Monthly price
- Not published
- FDA warning letter
- None found
Pricing transparency · How we grade · How we verify prices
The $79 covers the first three months only, billed as one $237 payment. The standard rate is $133 at $399, and it appears only after you click the Current User tab.
- Advertised $79, published $133
- No month-to-month price published
- Coverage not verified
The verdict
Every figure on this site is a three-month payment divided by three. The disclaimer says so, several screens below the number it explains.
Quick facts
Key facts
- Semaglutide, new patients
- $79 a month, $237 for three months
- Semaglutide, standard rate
- $133 a month, $399 for three months
- Tirzepatide, new patients
- $133 a month, $399 for three months
- One-month price
- None published anywhere on the site
- Billing
- Three months at a time, per the page's own disclaimer
- Price by dose?
- No. One price for all doses
- States served
- Not published on any page we read
Pros and cons
What we like
- One price for all doses, with no dose ladder and no titration surcharge anywhere on the pricing page.
- The standard rate does exist on the page — $133 — rather than being left to the checkout.
- The three-month billing structure is disclosed in writing rather than only appearing at payment.
- The compounded-medication disclaimer is repeated under every product card, not just once at the foot of the page.
What could be better
- No month-to-month price is published anywhere, so there is no answer to what a single month costs.
- The $79 headline is a first-three-months rate, and the standard $133 is hidden behind a tab until you click it.
- The comparison chart puts an introductory rate beside six competitors' standing rates without saying that is what it is doing.
- The terms name the company but no address of its own.
What it is
A compounded GLP-1 seller offering semaglutide and tirzepatide in injectable and oral forms, with a comparison chart against six named competitors as the centerpiece of its pricing page.
The oral prices are unconfirmed, so we cannot compare them with the injections. Separately, the compounded oral route carries its own questions.
Every price we found at NuuVim
| Plan | Advertised | Published price | The gap |
|---|---|---|---|
| Injectable semaglutide, new patients$79 covers the first three months at $237 total. After that the standard rate is $133 a month at $399 per three months. | $79 | $133 | |
| Injectable semaglutide, standard rate$399 billed as one three-month payment. Shown only under the Current User tab. | not published | $133 | not comparable |
| Injectable tirzepatide, new patients$399 for the first three months, billed as one payment. | not published | $133 | not comparable |
What it actually costs at NuuVim
There is no month-to-month price on this site. Every figure is a monthly equivalent of a three-month payment — $237 for semaglutide at the introductory rate, $399 at the standard one — and the line saying so sits under a competitor chart, not under the price.
The $79 the page is built around covers the first three months only. The standard rate is $133, and it appears only after you click a tab labeled Current User, which shows nothing until you do.
The comparison chart then puts NuuVim's introductory rate in the same column as six competitors' standing rates. The disclaimer covers the date the competitor figures were collected but not that the two columns are different kinds of number — and an introductory rate compared against a standing one is not a comparison.
Nothing on this site is billed by the month, so a monthly figure is a division rather than a charge. The totals behind each term are what actually leaves your account.
Who it's wrong for
- Skip it if you want to buy one month. There is no price for that, and the billing structure does not offer it.
- Skip it if you are price-shopping off the comparison chart. The column with NuuVim in it is an introductory rate; the others are not labeled as such.
- Skip it if you want the standing rate on the page you land on. Somira Health prints its monthly and quarterly rates together with both totals.
Medications available
- Injectable semaglutideCompounded$79 a month for three months, then $133
Billed as one three-month payment either way. No single-month option is published.
- Injectable tirzepatideCompounded$133 a month for the first three months
Same three-month billing structure.
- Oral semaglutide and oral tirzepatideCompounded
Described as a daily sublingual liquid. No price appeared in either oral block when we checked, so none is listed.
Is NuuVim legit?
NuuVim is operated by NuuVim LLC, according to its privacy notice.
No FDA warning letters found
Pharmacy, prescribers and safety checks
- Who prescribesNot named on the pricing page beyond "your medical provider"
- Pharmacy namedNot disclosed. The page states NuuVim does not manufacture
- Billing cadenceThree months at a time, disclosed under the comparison chart
- FDA warning letterNone found (checked October 2026)
- States servedNot published
Common questions
Is NuuVim really $79 a month?
Only for the first three months, and only as part of a single $237 payment. The standard rate afterward is $133 a month, charged as one $399 payment every three months.
How much does tirzepatide cost at NuuVim?
$133 a month for the first three months, billed as one payment of $399. Like the semaglutide rate beside it, that figure is a monthly equivalent of a three-month charge rather than a bill you can pay monthly.
Can I pay NuuVim monthly?
No monthly billing option is published. The disclaimer under the comparison chart states that the prices shown are monthly equivalents billed as one three-month payment.
Where is the standard rate on the page?
Behind a tab labeled Current User on each product block. That panel is empty until you click it, at which point the figure changes from $79 to $133 for semaglutide.
Why we gave NuuVim a C
Read the full grading rationale
NuuVim has no month-to-month price. Every figure is the monthly equivalent of a three-month payment, explained only in a disclaimer several screens below the $79 headline. That $79 is also a new-patient rate, $237 for the first three months; the standard rate is $133 a month at $399, shown only under a 'Current User' tab. Its comparison chart sets the intro rate against competitors' standard rates. One price for all doses, no membership fee. No state list.
Read the evidence
How we reviewed NuuVim
We read NuuVim's pricing page, homepage and terms of service.
The standard rate appears only after you click the Current User tab on the semaglutide block, so that is where we read it.
Where each price comes from
- Pricing page
New to GLP-1s Current User $79 / month $237 Total First 3 months · 3-month billing plan See “Current User” for standard and renewal rates.
Alternatives to NuuVim
| Provider | Grade | Published price context |
|---|---|---|
| 10rx | BMinor gap | Monthly medication total not confirmed — publishes $299 for semaglutide, quarterly plan |
| Actin | BMinor gap | From $169/mo for semaglutide |
| AgelessRx | CCaveat | From $159/mo for tirzepatide |
| AHBARx | BMinor gap | From $249/mo for semaglutide |
| Alan Meds | BMinor gap | From $315/mo for semaglutide |